Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris. Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Health Insurance and Managed Care, Medicare, Presidential Election of 2024, United States Politics and Government, Inflation Reduction Act of 2022, Medicare Advantage, Centers for Medicare and Medicaid Services, Biden, Joseph R Jr, Harris, Kamala D Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris. NYT > Business
Headlines